Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
2.670
+0.030 (1.14%)
Nov 20, 2024, 4:00 PM EST - Market closed
Moleculin Biotech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Selling, General & Admin | 8.88 | 10.02 | 11.54 | 8.39 | 6.79 | 6.31 | |
Research & Development | 19.91 | 19.49 | 18.97 | 14.42 | 12.76 | 11.01 | |
Operating Expenses | 28.92 | 29.63 | 30.64 | 22.97 | 19.74 | 17.52 | |
Operating Income | -28.92 | -29.63 | -30.64 | -22.97 | -19.74 | -17.52 | |
Interest & Investment Income | 0.77 | 1.37 | 0.24 | 0.31 | 0.01 | 0.01 | |
Other Non Operating Income (Expenses) | -2 | -1.51 | 1.38 | 6.77 | 2.37 | 4.08 | |
EBT Excluding Unusual Items | -30.15 | -29.77 | -29.03 | -15.89 | -17.36 | -13.43 | |
Pretax Income | -30.15 | -29.77 | -29.03 | -15.89 | -17.36 | -13.43 | |
Income Tax Expense | - | - | - | - | - | -0.23 | |
Net Income | -30.15 | -29.77 | -29.03 | -15.89 | -17.36 | -13.21 | |
Net Income to Common | -30.15 | -29.77 | -29.03 | -15.89 | -17.36 | -13.21 | |
Shares Outstanding (Basic) | 3 | 2 | 2 | 2 | 1 | 0 | |
Shares Outstanding (Diluted) | 3 | 2 | 2 | 2 | 1 | 0 | |
Shares Change (YoY) | 37.97% | 3.60% | 6.43% | 172.97% | 45.07% | 57.20% | |
EPS (Basic) | -11.22 | -15.07 | -15.22 | -8.87 | -26.44 | -29.18 | |
EPS (Diluted) | -11.22 | -15.07 | -15.22 | -8.87 | -26.44 | -29.18 | |
Free Cash Flow | -24.28 | -24.23 | -27.71 | -18.97 | -18.15 | -17.25 | |
Free Cash Flow Per Share | -9.03 | -12.26 | -14.53 | -10.59 | -27.65 | -38.12 | |
EBITDA | -28.79 | -29.5 | -30.51 | -22.8 | -19.54 | -17.33 | |
D&A For EBITDA | 0.13 | 0.13 | 0.13 | 0.16 | 0.2 | 0.2 | |
EBIT | -28.92 | -29.63 | -30.64 | -22.97 | -19.74 | -17.52 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.